Cargando…
Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients
BACKGROUND: Calcium polystyrene sulfonate (CPS) has long been used to treat hyperkalemia in patients with chronic kidney disease (CKD). However, its efficacy and safety profile have not been systematically explored. We investigated the long-term efficacy of oral CPS for treating mild hyperkalemia on...
Autores principales: | Yu, Mi-Yeon, Yeo, Jee Hyun, Park, Joon-Sung, Lee, Chang Hwa, Kim, Gheun-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362098/ https://www.ncbi.nlm.nih.gov/pubmed/28328954 http://dx.doi.org/10.1371/journal.pone.0173542 |
Ejemplares similares
-
Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
por: Nakayama, Takashin, et al.
Publicado: (2023) -
Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
por: Nakamura, Teruko, et al.
Publicado: (2018) -
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
por: Ren, Hongru, et al.
Publicado: (2022) -
Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018) -
Efficacy and safety of calcium polystyrene sulfonate in patients with
hyperkalemia and stage 3–5 non-dialysis chronic kidney disease: a single-center
randomized controlled trial
por: Wang, Xia, et al.
Publicado: (2023)